Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 5-Fluorouracil|DRUG: Cyclophosphamide|DRUG: Doxorubicin|DRUG: Paclitaxel|DRUG: Epirubicin
Sponsor: M.D. Anderson Cancer Center
Collaborators: Breast Cancer Research Foundation